NCT01975584

Brief Summary

This is a pilot study. We are testing the physiologic, immune and chemical responses to stress. We believe the results of all measures to stress will be blunted in schizophrenia compared to healthy controls. We will test sex, early life stress and other factors on the relationship to a stress response.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable schizophrenia

Timeline
Completed

Started Sep 2013

Longer than P75 for not_applicable schizophrenia

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2013

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 18, 2013

Completed
17 days until next milestone

First Posted

Study publicly available on registry

November 4, 2013

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2018

Completed
Last Updated

September 27, 2019

Status Verified

September 1, 2019

Enrollment Period

4.8 years

First QC Date

October 18, 2013

Last Update Submit

September 25, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Aim 1) To examine neuroendocrine and physiologic response following a psychosocial stressor in people with schizophrenia and healthy controls.

    We will administer the Trier Social Stress Test (TSST) and measure neuroendocrine values (plasma and salivary cortisol and adrenocorticotropic hormone (ACTH) and physiologic variables (heart rate, blood pressure) before during and after the TSST.

    1 week

Secondary Outcomes (1)

  • To investigate neuroimmune and kynurenic acid modulation to a psychosocial stressor in people with schizophrenia and healthy controls

    1 week

Study Arms (1)

Trier Social Stress Test

EXPERIMENTAL

Participants will participate in a standardized role play (Trier Social Stress Test ). A role play is pretending to be in a certain situation. A research staff member will describe the role play, during which teh participant will act out a scene. Participants will be asked to imagine that they are in a certain role with several other research team members who will also participate in the role play. Participants will also be asked to do some math problems without using paper or pencil.

Behavioral: Trier Social Stress Test

Interventions

Participants will participate in a standardized role play (Trier Social Stress Test ). A role play is pretending to be in a certain situation. A research staff member will describe the role play, during which teh participant will act out a scene. Participants will be asked to imagine that they are in a certain role with several other research team members who will also participate in the role play. Participants will also be asked to do some math problems without using paper or pencil.

Trier Social Stress Test

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • DSM-IV diagnosis of schizophrenia or schizoaffective disorder (schizophrenia group)
  • No DSM-IV Axis I or II disorder (healthy control group)
  • Caucasian or Non-Caucasian

You may not qualify if:

  • History of Cushing's syndrome, adrenal deficiency, or any condition that may affect cortisol levels in the body.
  • Use of steroids
  • Pregnancy or lactation. Pregnancy will be determined by urine pregnancy test. Lactation will be determined through patient report.
  • Untreated hypertension, cardiac arrthymias or medical condition that could not handle stress.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maryland Psychiatric Research Center

Catonsville, Maryland, 21228, United States

Location

Related Links

MeSH Terms

Conditions

SchizophreniaPsychotic Disorders

Interventions

Psychological Tests

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Behavioral Disciplines and Activities

Study Officials

  • Deanna L Kelly, PharmD, BCPP

    University of Maryland, College Park

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Pharm.D., BCPP

Study Record Dates

First Submitted

October 18, 2013

First Posted

November 4, 2013

Study Start

September 1, 2013

Primary Completion

June 1, 2018

Study Completion

June 1, 2018

Last Updated

September 27, 2019

Record last verified: 2019-09

Locations